Clinical trial

Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm…

NCT00220987 · The George Institute, Other · Completed

Key facts

NCT number NCT00220987
Title Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE - SUGAR STUDY)
Official title A Multi-Center, Open Label Randomized Stratified Controlled Trial of the Effects of Blood Glucose Management on 90-Day All-Cause Mortality in a Heterogenous Population of Intensive Care Unit (ICU) Patients.
Lead sponsor The George Institute, Other
Collaborators Australian and New Zealand Intensive Care Society Clinical Trials Group Canadian Critical Care Trials Group National Health and Medical Research Council, Australia Health Research Council, New Zealand…
Status Completed
Phase Phase 4
Study type Interventional
Conditions Hyperglycemia, Critical Illness
Intervention type Other
Interventions Intensive Insulin Therapy, Conventional Insulin therapy
Enrollment 6,104
Start date Apr 1, 2005
Primary completion Nov 1, 2008
Completion Nov 1, 2008
First posted Sep 22, 2005
Last update posted Jan 29, 2009
Countries Australia

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies